Noninvasive prenatal testing (NIPT also called as NIPS), is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This test analyzes small fragments of DNA that are circulating in a pregnant woman’s blood. NIPT primarily looks for Down syndrome, Trisomy 18, Trisomy 13, and extra or missing copies of the X chromosome and Y chromosome. The accuracy of the test varies by disorder. NIPT is a screening test, which means that it will not give a definitive answer about whether or not a fetus has a genetic condition. The test can only estimate whether the risk of having certain conditions is increased or decreased. A positive screening result indicates that further testing called diagnostic testing should be performed to confirm the result.